Strand Therapeutics
Biotechnology, 237 Putnam Ave, Boston, Massachusetts, 02139, United States, 51-200 Employees
Phone Number: 13*********
Who is STRAND THERAPEUTICS
Strand was founded by biological engineers working together at the Massachusetts Institute of Technology (MIT). Building on the idea of creating smart therapies capable of making sophisti...
Read More
- Headquarters: 237 Putnam Ave, Boston, Massachusetts, 02139, United States
- Date Founded: 2017
- Employees: 51-200
- Revenue: $1 Million to $5 Million
- Active Tech Stack: See technologies
- CEO: Jacob Becraft
Industry: Biotechnology
SIC Code: 2836 | NAICS Code: 541714 | Show More
Does something look wrong? Fix it. | View contact records from STRAND THERAPEUTICS
Strand Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Strand Therapeutics
Answer: Strand Therapeutics's headquarters are located at 237 Putnam Ave, Boston, Massachusetts, 02139, United States
Answer: Strand Therapeutics's phone number is 13*********
Answer: Strand Therapeutics's official website is https://strandtx.com
Answer: Strand Therapeutics's revenue is $1 Million to $5 Million
Answer: Strand Therapeutics's SIC: 2836
Answer: Strand Therapeutics's NAICS: 541714
Answer: Strand Therapeutics has 51-200 employees
Answer: Strand Therapeutics is in Biotechnology
Answer: Strand Therapeutics contact info: Phone number: 13********* Website: https://strandtx.com
Answer: Strand was founded by biological engineers working together at the Massachusetts Institute of Technology (MIT). Building on the idea of creating smart therapies capable of making sophisticated decisions, they sought to apply this concept to the emerging field of mRNA therapeutics. This area was previously untapped by traditional synthetic biology, leading us to build our very own mRNA programming language, creating the worlds first platform for mRNA smart therapies. Strands mRNA programming technology promises to make mRNA therapies safer and more effective by programming the location, timing, and intensity of therapeutic protein expression inside a patients body via mRNA-encoded logic circuits. These circuits have the ability to implement cell-type specific expressions by sensing and classifying the unique mRNA expression signatures of cells and control the dosage of protein expression through responses to exogenously administered small molecules.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month